Announcement • Jun 28
FunPep Company Limited to Report Q2, 2026 Results on Aug 14, 2026 FunPep Company Limited announced that they will report Q2, 2026 results on Aug 14, 2026 New Risk • Jun 06
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 35% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (35% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (JP¥2.68b market cap, or US$16.7m). Announcement • Mar 11
FunPep Company Limited announced that it has received ¥32.5315 million in funding from Next Growth Co., Ltd., Growth Capital, Inc. On March 9, 2026. FunPep Company Limited announces that it has closed the transaction. Announcement • Feb 12
FunPep Company Limited, Annual General Meeting, Mar 26, 2026 FunPep Company Limited, Annual General Meeting, Mar 26, 2026. New Risk • Feb 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 0% over the past year. Revenue is less than US$1m (JP¥3.0m revenue, or US$19k). Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (JP¥3.69b market cap, or US$23.5m). Announcement • Jan 06
FunPep Company Limited to Report Fiscal Year 2025 Results on Feb 12, 2026 FunPep Company Limited announced that they will report fiscal year 2025 results on Feb 12, 2026 Announcement • Oct 10
FunPep Company Limited to Report Q3, 2025 Results on Nov 14, 2025 FunPep Company Limited announced that they will report Q3, 2025 results on Nov 14, 2025 New Risk • Aug 25
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 44% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (44% increase in shares outstanding). Revenue is less than US$1m (JP¥6.0m revenue, or US$41k). Minor Risk Market cap is less than US$100m (JP¥4.75b market cap, or US$32.2m). Announcement • Jun 27
FunPep Company Limited to Report Q2, 2025 Results on Aug 14, 2025 FunPep Company Limited announced that they will report Q2, 2025 results on Aug 14, 2025 New Risk • May 14
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Revenue is less than US$1m (JP¥6.0m revenue, or US$41k). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (JP¥3.47b market cap, or US$23.6m). Announcement • Apr 09
FunPep Company Limited to Report Q1, 2025 Results on May 14, 2025 FunPep Company Limited announced that they will report Q1, 2025 results on May 14, 2025 Announcement • Mar 10
FunPep Company Limited announced that it has received ¥3.6 million in funding from SBI Securities Co., Ltd. On March 10,2025, the company has closed the transaction. Announcement • Feb 12
FunPep Company Limited, Annual General Meeting, Mar 27, 2025 FunPep Company Limited, Annual General Meeting, Mar 27, 2025. New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 34% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (34% increase in shares outstanding). Revenue is less than US$1m (JP¥3.0m revenue, or US$19k). Minor Risk Market cap is less than US$100m (JP¥4.34b market cap, or US$27.8m). Announcement • Jan 03
FunPep Company Limited to Report Fiscal Year 2024 Results on Feb 12, 2025 FunPep Company Limited announced that they will report fiscal year 2024 results on Feb 12, 2025 Announcement • Sep 13
FunPep Company Limited to Report Q3, 2024 Results on Nov 14, 2024 FunPep Company Limited announced that they will report Q3, 2024 results on Nov 14, 2024 Announcement • Jun 27
FunPep Company Limited to Report Q2, 2024 Results on Aug 08, 2024 FunPep Company Limited announced that they will report Q2, 2024 results on Aug 08, 2024 Announcement • Apr 10
FunPep Company Limited to Report Q1, 2024 Results on May 13, 2024 FunPep Company Limited announced that they will report Q1, 2024 results on May 13, 2024 Announcement • Mar 21
FunPep Company Limited announced that it has received ¥199.9998 million in funding from Shionogi & Co., Ltd. On March 21, 2024, FunPep Company Limited closed the transaction. New Risk • Mar 05
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 100% over the past year. Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (13% increase in shares outstanding). Market cap is less than US$100m (JP¥4.24b market cap, or US$28.2m). Announcement • Mar 04
FunPep Company Limited announced that it expects to receive ¥199.9998 million in funding from Shionogi & Co., Ltd. FunPep Company Limited announced that it has entered into an option agreement with returning investor Shionogi & Co., Ltd. who holds holding 1,095,200 shares to issue 1,587,300 common shares at an issue price of ¥126 per share for the gross proceeds of ¥197,499,800 on March 4, 2024. The transaction has been approved by the shareholders of the company and is expected to close on March 21, 2024. The company has disclosed the issue expenses of ¥2,500,000 and the net proceeds of ¥197,499,800. Announcement • Feb 16
FunPep Company Limited, Annual General Meeting, Mar 27, 2024 FunPep Company Limited, Annual General Meeting, Mar 27, 2024. Announcement • Feb 07
FunPep Company Limited to Report Fiscal Year 2023 Results on Feb 14, 2024 FunPep Company Limited announced that they will report fiscal year 2023 results on Feb 14, 2024 Announcement • Oct 05
FunPep Company Limited to Report Q3, 2023 Results on Nov 14, 2023 FunPep Company Limited announced that they will report Q3, 2023 results on Nov 14, 2023 Announcement • May 28
FunPep Company Limited to Report Q2, 2023 Results on Aug 14, 2023 FunPep Company Limited announced that they will report Q2, 2023 results on Aug 14, 2023 Reported Earnings • Feb 16
Full year 2022 earnings released: JP¥61.01 loss per share (vs JP¥39.56 loss in FY 2021) Full year 2022 results: JP¥61.01 loss per share (further deteriorated from JP¥39.56 loss in FY 2021). Net loss: JP¥1.17b (loss widened 72% from FY 2021). Announcement • Dec 06
FunPep Company Limited to Report Fiscal Year 2022 Results on Feb 14, 2023 FunPep Company Limited announced that they will report fiscal year 2022 results on Feb 14, 2023 Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Tsutomu Une was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Aug 28
FunPep Company Limited to Report Q3, 2022 Results on Nov 14, 2022 FunPep Company Limited announced that they will report Q3, 2022 results on Nov 14, 2022 Announcement • Jul 16
FunPep Company Limited (TSE:4881) agreed to acquire Anti-Aging Peptide. FunPep Company Limited (TSE:4881) agreed to acquire Anti-Aging Peptide Co., Ltd. from Hironori Nakagami , Bio Site Start Fund L.P., Naotaka Hashiya, Chiyako Ueda, ReBeage Co., Ltd. and others on July 14, 2022. As per the teams of the deal 6,500 shares of the FunPep Company Limited will be allotted and delivered for each Anti-Aging Peptide share. Anti-Aging Peptide Co., Ltd. reported Net worth of JPY68 million, Total assets of JPY68 million, Operating loss(EBIT) of JPY1 million and Net loss of JPY 3 million for the year ended December 31, 2021. Deal is subject to subject to approval at the extraordinary general meeting of shareholders. Share Exchange is expected to be effective on October 1, 2022. Announcement • Jun 29
FunPep Company Limited to Report Q2, 2022 Results on Aug 12, 2022 FunPep Company Limited announced that they will report Q2, 2022 results on Aug 12, 2022 Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Tsutomu Une was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Apr 10
FunPep Company Limited to Report Q1, 2022 Results on May 13, 2022 FunPep Company Limited announced that they will report Q1, 2022 results on May 13, 2022 Announcement • Feb 17
FunPep Company Limited, Annual General Meeting, Mar 29, 2022 FunPep Company Limited, Annual General Meeting, Mar 29, 2022. Announcement • Dec 14
FunPep Company Limited announced that it has received ¥3.741 million in funding from SBI Securities Co., Ltd., Investment Arm ON December 13, 2021, FunPep Company Limited closed the transaction. Announcement • Nov 27
FunPep Company Limited announced that it expects to receive ¥3.741 million in funding from SBI Securities Co., Ltd., Investment Arm FunPep Company Limited announced a third-party allotment agreement for a private placement of 43,000 units of the 9th stock acquisition rights at an issue price of ¥87 per stock acquisition right for gross proceeds of ¥3,741,000 on November 26 2021. The transaction will involve participation from SBI Securities Co., Ltd., Investment Arm. The stock acquisition right may be converted into 4,300,000 shares (100 shares per stock acquisition right), with initial exercise price of ¥297 per share. The company will pay issuance expenses, including attorney's fees, valuation calculation costs, trust bank costs, etc. of ¥12,000,000. The period during which the stock acquisition rights can be exercised from December 14, 2021 to December 13, 2023. The allotment date is December 13, 2021. The transaction is approved by the board of directors of the company Reported Earnings • Apr 01
Full year 2020 earnings released: JP¥40.30 loss per share (vs JP¥20.23 loss in FY 2019) Full year 2020 results: Net loss: JP¥507.0m (loss widened 116% from FY 2019). Reported Earnings • Feb 14
Full year 2020 earnings released: JP¥40.30 loss per share (vs JP¥20.23 loss in FY 2019) Full year 2020 results: Net loss: JP¥507.0m (loss widened 116% from FY 2019). Announcement • Feb 12
FunPep Company Limited, Annual General Meeting, Mar 25, 2021 FunPep Company Limited, Annual General Meeting, Mar 25, 2021. 
